[INM] QoQ Quarter Result on 31-Mar-2022 [#Q3]

Stock
[INM] InMed Pharmaceuticals Inc.
Announcement Date
13-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q3]
Profit Trend
QoQ- 18.84%
YoY- -12.09%
Quarter Report
INM's Result
INM's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 470 321 515 310 265 0 0 -
PBT -2,098 -3,503 -7,870 -3,476 -4,283 -2,972 -3,259 -25.38%
Tax 3 7 -34 -31 22 79 10 -55.08%
NP -2,101 -3,510 -7,870 -3,476 -4,283 -2,972 -3,259 -25.31%
Tax Rate - - - - - - - -
Total Cost 2,571 3,831 8,385 3,785 4,548 2,972 3,259 -14.58%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -447.25 -1,094.24 -1,528.88 -1,122.69 -1,615.60 0.00 0.00 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.91 -4.06 -12.22 -6.14 -7.73 -6.17 -10.13 -79.85%
EPS Diluted -0.91 -4.06 -12.22 -6.14 -7.73 -6.17 -10.13 -79.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.